跳至主要内容
临床试验/DRKS00030404
DRKS00030404已完成4 期

The Impact of Biological Gender in Peripheral Nerve Blockade: A Prospective Study in Volunteers

Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie0 个研究点目标入组 24 人开始时间: 2023年1月4日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • Healthy males and females
  • -Healthy, according to the medical history, ECG, vital signs, laboratory results and physical examination as determined by the Investigator/Sub-Investigator
  • -Signed written informed consent prior to inclusion in the study
  • -18-55 years old inclusive
  • -BMI: 18 to 35 kg/m2
  • -Ability to understand the full nature and purpose of the study, including possible risks and side effects
  • -Ability to co-operate with the investigator and to comply with the requirements of the entire study
  • -Availability to volunteer for the entire study duration and willing to adhere to all protocol requirements

排除标准

  • -Any clinically relevant abnormalities at ECG (12 leads)
  • -Any clinically relevant abnormal physical findings
  • -Any clinically relevant abnormal laboratory values indicative of physical illness
  • -Ascertained or presumptive hypersensitivity to the active principle and/or formulations ingredients of the study drug
  • -History of anaphylaxis to drugs or allergic reactions in general, which the investigator considers may affect the outcome of the study
  • -Pregnancy (female volunteers)
  • -Relevant history of malignancy, of renal, hepatic, cardiovascular, respiratory, gastrointestinal, musculoskeletal, skin (particularly at the site of drug application), haematological, endocrine or neurological diseases that may interfere with the aim of the study
  • -Any psychiatric illnesses
  • -Using other medications during 1 week before the start of IMP application including OTC
  • -Participation in another clinical study investigating another IMP within 1 month prior to screening
  • -Blood donations during 4 weeks prior to this study
  • -History of drug or alcohol abuse (>2 drinks/day, defined according to USDA Dietary Guidelines 2015)
  • -Other objections to study participation in the opinion of the investigator

研究者

发起方
Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie

相似试验

The Impact of Biological Gender in Peripheral Nerve... | 临床试验